Under-reporting of adverse drug reactions : a systematic review.

作者: Lorna Hazell , Saad A W Shakir

DOI: 10.2165/00002018-200629050-00003

关键词:

摘要: The purpose of this review was to estimate the extent under-reporting adverse drug reactions (ADRs) spontaneous reporting systems and investigate whether there are differences between different types ADRs. A systematic literature search carried out identify studies providing a numerical under-reporting. Studies were included regardless methodology used or setting, e.g. hospital versus general practice. Estimates either extracted directly from published study calculated data. These expressed as percentage ADRs detected intensive data collection that not reported relevant local, regional national systems. median rate across all within subcategories using methods settings. In total, 37 wide variety surveillance identified 12 countries. generated 43 estimates 94% (interquartile range 82-98%). There no significant difference in rates for practice hospital-based studies. Five ten provided evidence higher compared with more serious severe (95% 80%, respectively). comparison, five eight remained high (95%). lower 19 investigating specific serious/severe ADR-drug combinations but still at 85%. This provides widespread including Further work is required assess impact on public health decisions effects initiatives improve such internet reporting, pharmacist/nurse direct patient well improved education training healthcare professionals.

参考文章(67)
A. Alvarez-Requejo, A. Carvajal, B. Bégaud, Y. Moride, T. Vega, L. H. Martín Arias, Under-reporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and a sentinel system. European Journal of Clinical Pharmacology. ,vol. 54, pp. 483- 488 ,(1998) , 10.1007/S002280050498
Nicole Mittmann, Sandra R Knowles, Manuel Gomez, Joel S Fish, Robert Cartotto, Neil H Shear, Evaluation of the extent of under-reporting of serious adverse drug reactions: the case of toxic epidermal necrolysis. Drug Safety. ,vol. 27, pp. 477- 487 ,(2004) , 10.2165/00002018-200427070-00004
Colt Am, Andrews Lg, Scott Hd, Juergens Jp, Faich Ga, Rosenbaum Se, Waters Wj, Rhode Island physicians' recognition and reporting of adverse drug reactions. Rhode Island medical journal. ,vol. 70, pp. 311- ,(1987)
Priya Bahri, Panos Tsintis, Patrick C. Waller, Regulatory Pharmacovigilance in the EU John Wiley & Sons, Ltd. pp. 185- 198 ,(2007) , 10.1002/9780470059210.CH14
Patrick Waller, J. C. C. Talbot, Stephens' detection of new adverse drug reactions John Wiley & Sons. ,(2004)
Eland, Belton, Van Grootheest, Meiners, Rawlins, Stricker, Attitudinal survey of voluntary reporting of adverse drug reactions. British Journal of Clinical Pharmacology. ,vol. 48, pp. 623- 627 ,(1999) , 10.1046/J.1365-2125.1999.00060.X
Dianne L. Kennedy, Stephen A. Goldman, Ralph B. Lillie, Spontaneous Reporting in the United States John Wiley & Sons, Ltd. pp. 149- 174 ,(2002) , 10.1002/0470842555.CH10
Bengt-Erik Wiholm, Sten Olsson, Nicholas Moore, Patrick Waller, Spontaneous Reporting Systems Outside the US John Wiley & Sons, Ltd. pp. 175- 192 ,(2002) , 10.1002/0470842555.CH11
H. Bagheri, F. Michel, M. Lapeyre-Mestre, E. Lagier, J. P. Cambus, P. Valdiguié, J. L. Montastruc, Detection and incidence of drug-induced liver injuries in hospital: a prospective analysis from laboratory signals. British Journal of Clinical Pharmacology. ,vol. 50, pp. 479- 484 ,(2000) , 10.1046/J.1365-2125.2000.00282.X
Corinne Pierfitte, Bernard Bégaud, Rajaa Lagnaoui, Nicholas D. Moore, Is reporting rate a good predictor of risks associated with drugs British Journal of Clinical Pharmacology. ,vol. 47, pp. 329- 331 ,(1999) , 10.1046/J.1365-2125.1999.00881.X